All articles by Victoria Smith

  1. How Transport Simulation Testing Benefits Fast-Track Approval Timeline

    FDA Fast-Track designation compresses approximately eight years of development and validation activities into roughly 18 months. To meet this accelerated…
    Read More…

    7 Jul
  2. The dominance of Eylea is expected to persist in the foreseeable future

    Bayer/Regeneron’s Eylea (aflibercept) is a fusion protein utilised in the treatment of retinal diseases frequently exacerbated by choroidal neovascularisation, a…
    Read More…

    1 Jul
  3. Significant clinical unmet needs remain in idiopathic pulmonary fibrosis

    Idiopathic pulmonary fibrosis (IPF) remains an area of high unmet clinical need. GlobalData has identified four key unmet needs in…
    Read More…

    1 Jul
  4. Will Zeposia change the treatment paradigm in IBD?

    At present, there is an unmet need for novel oral drug formulations in inflammatory bowel disease (IBD) patients suffering from…
    Read More…

    1 Jul
  5. “There’s going to be more than one winner in the vaccine field” Says US top infectious disease expert Dr Anthony Fauci

    US public health expert Dr Anthony Fauci, leading federal efforts to combat Covid-19, considers there will be more than one…
    Read More…

    30 Jun
  6. Chronic kidney disease patients likely to go undiagnosed due to Covid-19 pandemic

    At present, the UK has over 301,000 total confirmed cases of the coronavirus disease 2019 (Covid-19), making it the fifth…
    Read More…

    30 Jun
  7. How to stand out from the crowd: What Big Pharma looks for when acquiring

    Specialists in the Pharmaceutical deal-making scope met virtually for the 2020 BIO International Convention last week to discuss the topic…
    Read More…

    29 Jun
  8. Dexamethasone and remdesivir could be used in combination

    After obtaining a world-first approval by the UK Government, the low-priced and broadly accessible corticosteroid dexamethasone has received notable attention…
    Read More…

    29 Jun
  9. Major pharmaceutical markets are severely deficient in the diagnosis of dry eye syndrome

    Dry eye syndrome is an ailment induced by a lack of adequate tears, which are essential for supporting eye health…
    Read More…

    26 Jun
  10. North China: Easing of Covid-19 lockdown represents investment opportunities for international companies

    The Northern Chinese province of Hebei, a leading region for pharmaceutical production, will offer excellent potential for pharma investment as…
    Read More…

    24 Jun
Close
Close
Close

Go Top